By: Benzinga
Citigroup Reiterates Buy Rating, $58 PT on Magellan Health Services
In a report published Monday, Citigroup reiterated its Buy rating and $58.00 price target on Magellan Health Services (NASDAQ: MGLN ). Citigroup noted, “On Monday, Magellan announced the loss of its contract with Horizon Blue Cross Blue Shield in New Jersey. We estimate this contract will generate $193 million in
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here